Loading...
XNYSCCM
Market cap6mUSD
Dec 24, Last price  
4.52USD
1D
0.35%
1Q
-30.52%
Jan 2017
-1.72%
IPO
-38.07%
Name

Concord Medical Services Holdings Ltd

Chart & Performance

D1W1MN
XNYS:CCM chart
P/E
—
P/S
0.27
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-36.81%
Rev. gr., 5y
23.00%
Revenues
537m
+13.84%
171,789,000292,436,000389,524,000450,125,000672,056,000974,577,000606,883,000616,485,000455,042,000330,977,000190,898,000198,363,000223,011,000485,633,000472,085,000537,402,000
Net income
-298m
L-61.29%
79,069,000124,827,000129,400,000-215,003,000129,802,00088,355,000124,709,000-79,438,000-261,867,000-284,320,000-234,875,000-352,092,000-404,029,000-522,672,000-768,990,000-297,658,000
CFO
-276m
L+27.59%
46,774,000135,883,000190,972,000137,102,000259,515,000259,033,000490,381,000-175,138,000-78,078,00026,732,000-38,591,000-195,347,000-229,766,000-359,313,000-216,694,000-276,471,000
Dividend
Dec 23, 20150.99 USD/sh

Profile

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
URL
http://www.concordmedical.com/
IPO date
Dec 11, 2009
Employees
918
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
537,402
13.84%
472,085
-2.79%
485,633
117.76%
Cost of revenue
979,022
997,133
943,951
Unusual Expense (Income)
NOPBT
(441,620)
(525,048)
(458,318)
NOPBT Margin
Operating Taxes
24,573
(70,906)
(6,565)
Tax Rate
NOPAT
(466,193)
(454,142)
(451,753)
Net income
(297,658)
-61.29%
(768,990)
47.13%
(522,672)
29.36%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,088,680
548,499
319,836
Long-term debt
2,446,520
2,927,249
2,647,530
Deferred revenue
81,210
Other long-term liabilities
49,003
64,084
3,254
Net debt
3,082,350
2,879,591
2,419,355
Cash flow
Cash from operating activities
(276,471)
(216,694)
(359,313)
CAPEX
(115,702)
(384,806)
(780,293)
Cash from investing activities
(47,681)
(118,792)
(565,981)
Cash from financing activities
257,653
383,088
642,449
FCF
(869,320)
(602,223)
(600,260)
Balance
Cash
58,139
158,283
157,386
Long term investments
394,711
437,874
390,625
Excess cash
425,980
572,553
523,729
Stockholders' equity
(260,971)
85,031
807,176
Invested Capital
5,352,662
5,205,810
5,016,159
ROIC
ROCE
EV
Common stock shares outstanding
4,368
43,685
43,685
Price
0.37
-32.93%
0.55
-18.00%
0.67
-27.01%
Market cap
1,602
-93.29%
23,881
-18.00%
29,123
-27.01%
EV
6,952,884
6,783,095
6,562,315
EBITDA
(313,166)
(392,234)
(354,238)
EV/EBITDA
Interest
120,357
73,789
Interest/NOPBT